The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
AMCP Foundation Awards Pharmacy & Therapeutics Competition Winners
April 4th 2019By participating in the P&T Competition, student pharmacists gain experience in gathering and critically analyzing scientific, clinical, and economic evidence in a systematic and rigorous fashion, according to the foundation.
Read More
FDA Officials Reject NDA, in Current Form, for Gastroparesis Treatment
April 3rd 2019If approved, Gimoti would be the first non-oral drug treatment for symptoms associated with acute and recurrent diabetic gastroparesis in adult women and would represent the first significant advancement in the treatment of gastroparesis in 40 years.
Read More
Reassuring Parents Who Are on the Fence About Vaccines
April 3rd 2019Mary Koslap‐Petraco DNP, PNPPC‐BC, CPNP, FAANP of Stony Brook University School of Nursing and Pediatric Nurse Practitioner House Calls advises nurses to listen to concerned parents and assure them they want the best for their children.
Watch